Opportunity Information: Apply for RFA NS 13 001
Apply for RFA NS 13 001
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Limited Competition for Continuation of the NIH Exploratory Trials in Parkinsons Disease (NET PD) Coordinating and Statistical Centers (U01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders.
- This funding opportunity was created on Jan 31, 2012 and posted on Jan 31, 2012.
- Applicants must submit their applications by Apr 17, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $4,000,000.00 to eligible and selected applicants.
- The number of recipients for this funding is limited to 2 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Other Eligible Applicants include the following Only currently active NET PD Coordinating and Statistical Centers are eligible to apply. Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This grant opportunity (RFA-NS-13-001) is a limited-competition NIH Cooperative Agreement (U01) from the National Institute of Neurological Disorders and Stroke (NINDS) designed to continue support for the key infrastructure that runs the NIH Exploratory Trials in Parkinson's Disease (NET-PD) network. The central purpose is not to launch new NET-PD studies, but to make sure the network's current, already underway clinical trials can be completed successfully by maintaining the operational and statistical backbone required to coordinate multi-site Parkinson's disease trials.
The FOA specifically seeks applications to support the NET-PD Coordinating and Statistical Centers, described in the announcement as the Clinical and Data Coordinating Centers. In practical terms, this type of support generally covers the functions that keep ongoing trials moving in a consistent, compliant, and scientifically rigorous way across participating clinical sites: trial coordination and management, data collection and quality control, statistical design and analysis, centralized reporting, and other coordination tasks that ensure studies remain on schedule and produce interpretable results. Because the funding mechanism is a cooperative agreement (U01), the NIH typically expects substantial programmatic involvement from NINDS staff during the project period, meaning awardees work in close partnership with the Institute rather than operating entirely independently as in a traditional research grant.
Competition is explicitly restricted. Only currently active NET-PD Coordinating and Statistical Centers are eligible to apply, making this a continuation opportunity intended for existing network hubs rather than an open solicitation to the broader research community. Foreign institutions are not eligible, and foreign components of U.S. organizations are not allowed, which keeps the work fully domestic under NIH policy for this FOA. The opportunity is categorized as discretionary funding in the health area, with no cost sharing or matching requirement.
NINDS anticipated making two awards under this announcement, with an estimated total funding level of $4,000,000. The CFDA listing associated with the program is 93.853 (Extramural Research Programs in the Neurosciences and Neurological Disorders). The FOA was posted and created on January 31, 2012, with an original and current application closing date of April 17, 2012, and an archive date of May 18, 2012, indicating it is no longer active for submission.
For reference and full details, the FOA was published through the NIH Grants Guide under the link provided in the source data (http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-13-001.html). For technical issues accessing the announcement, the listed contact is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
FAQs: NIH NINDS NET-PD Infrastructure Support (RFA-NS-13-001, U01)
What is RFA-NS-13-001?
RFA-NS-13-001 is a limited-competition NIH funding opportunity from the National Institute of Neurological Disorders and Stroke (NINDS). It uses the Cooperative Agreement mechanism (U01) and is focused on continuing support for the key infrastructure that operates the NIH Exploratory Trials in Parkinson's Disease (NET-PD) network.
What is the main purpose of this funding opportunity?
The central purpose is to ensure that NET-PD clinical trials that are already underway can be completed successfully. The funding is intended to maintain the operational and statistical backbone needed to coordinate multi-site Parkinson's disease trials, rather than to launch new NET-PD studies.
Is this opportunity intended to start new NET-PD studies?
No. The announcement explicitly emphasizes continuation support for infrastructure so existing, ongoing NET-PD trials can be completed, not the initiation of new NET-PD studies.
What types of centers does the FOA seek to support?
The FOA seeks applications to support the NET-PD Coordinating and Statistical Centers, described as the Clinical and Data Coordinating Centers.
What activities are typically supported through the Coordinating and Statistical Centers?
Based on the description provided, supported activities generally include functions that keep ongoing multi-site trials consistent, compliant, and scientifically rigorous, such as:
- Trial coordination and management across participating clinical sites
- Data collection processes and data quality control
- Statistical design and statistical analysis support
- Centralized reporting and coordination tasks
- Operational support to help keep studies on schedule and results interpretable
What funding mechanism is used?
This opportunity uses an NIH Cooperative Agreement (U01) mechanism.
What does the U01 cooperative agreement imply about NIH involvement?
Because this is a cooperative agreement, the NIH (through NINDS) typically expects substantial programmatic involvement from NINDS staff during the project period. Awardees are expected to work in close partnership with the Institute rather than operating entirely independently as they would under a traditional research grant.
Who is eligible to apply?
Eligibility is explicitly restricted. Only currently active NET-PD Coordinating and Statistical Centers are eligible to apply. This makes it a continuation opportunity for existing NET-PD network hubs rather than an open competition for the broader research community.
Is this a limited-competition opportunity?
Yes. Competition is restricted to currently active NET-PD Coordinating and Statistical Centers.
Are foreign institutions eligible to apply?
No. Foreign institutions are not eligible under this FOA.
Are foreign components of U.S. organizations allowed?
No. Foreign components of U.S. organizations are not allowed under this FOA, meaning the work is intended to remain fully domestic for this announcement.
Is cost sharing or matching required?
No. The opportunity indicates there is no cost sharing or matching requirement.
How many awards did NINDS anticipate making?
NINDS anticipated making two awards under this announcement.
What was the estimated total funding level?
The estimated total funding level described for this announcement was $4,000,000.
What is the CFDA number associated with this program?
The CFDA listing associated with the program is 93.853 (Extramural Research Programs in the Neurosciences and Neurological Disorders).
What is the focus area or topic of the funded work?
The work supports infrastructure for multi-site clinical trials in Parkinson's disease within the NIH NET-PD network.
What is the application deadline for RFA-NS-13-001?
The application closing date listed for this FOA was April 17, 2012.
Is this FOA still active?
No. The archive date is May 18, 2012, indicating the announcement is no longer active for submission.
When was the FOA posted?
The FOA was posted/created on January 31, 2012.
Where can applicants find the official FOA details?
The FOA was published through the NIH Grants Guide at: http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-13-001.html
Who can be contacted for technical issues accessing the announcement?
For technical issues accessing the announcement, the listed contact is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
What kind of funding category is this opportunity described as?
It is categorized as discretionary funding in the health area.
Browse more opportunities from the same category: Health
Next opportunity: Limited Competition for Continuation of the NIH Exploratory Trials in Parkinsons Disease (NET PD) Clinical Sites (U10)
Previous opportunity: Marketing Innovation For Health
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA NS 13 001
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA NS 13 001) also looked into and applied for these:
| Funding Opportunity |
|---|
| Limited Competition for Continuation of the NIH Exploratory Trials in Parkinsons Disease (NET PD) Clinical Sites (U10) Apply for RFA NS 13 002 Funding Number: RFA NS 13 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Resource support for Consortiums for HIV/AIDS and Alcohol Related Outcomes Research Trials (CHAART) U24 Apply for RFA AA 12 010 Funding Number: RFA AA 12 010 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Strengthening Federal Coordination and Monitoring and Evaluation of the Multi Sectoral response to HIV/AIDS in Ethiopia under the Presidents Emergency Plan for AIDS Relief (PEPFAR). Apply for CDC RFA GH12 1220 Funding Number: CDC RFA GH12 1220 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,050,000 |
| HIV Vaccine Research and Design (HIVRAD) Program (P01) Apply for PAR 12 087 Funding Number: PAR 12 087 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Strengthening of the National External Quality Assessment (EQA) Program through Establishment and Implementation of an Efficient Distribution and Analysis of Proficiency Materials for Human Immunodeficiency Virus (HIV), Tuberculosis, and Opportunisti Apply for CDC RFA GH12 1234 Funding Number: CDC RFA GH12 1234 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $250,000 |
| Partnerships for Development of Vaccine Technologies (R01) Apply for RFA AI 12 014 Funding Number: RFA AI 12 014 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Resource Access for the Bridging Interventional Development Gaps Program (X01) Apply for PAR 12 092 Funding Number: PAR 12 092 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NU HITES Apply for RFA 617 12 000005 Funding Number: RFA 617 12 000005 Agency: Uganda USAID Kampala Category: Health Funding Amount: $50,000,000 |
| Strengthening Systems, Capacity, and Data Collection with a Focus on Strategic Information in South Sudan under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 1256 Funding Number: CDC RFA GH12 1256 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,000,000 |
| Engaging Local Indigenous Organizations in Improving Quality and Efficiency of HIV Care and Treatment Services in Ukraine under the Presidents Emergency Plan for HIV/AIDS Relief (PEPFAR) Apply for CDC RFA GH12 1227 Funding Number: CDC RFA GH12 1227 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $700,000 |
| Establishment of an expanded Caribbean HIV/AIDS monitoring and evaluation technical assistance unit within the Caribbean Health Research Council (CHRC) under the Presidents Emergency Plan for AIDS Relief (PEPFAR Apply for CDC RFA GH12 1205 Funding Number: CDC RFA GH12 1205 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $400,000 |
| Planning Grant The Money Follows the Person Rebalancing Demonstration Program Apply for CMS 1LI 12 001 Funding Number: CMS 1LI 12 001 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $200,000 |
| Expanding Participation of People with Disabilities in USAID Activities andStrengthen the Capacities of Disabled Peoples Organizations (DPOs) Apply for RFA 114 12 000002 Funding Number: RFA 114 12 000002 Agency: Georgia USAID Tbilisi Category: Health Funding Amount: $600,000 |
| Implementation of a Program to Build the Institutional Apply for CDC RFA GH12 1243 Funding Number: CDC RFA GH12 1243 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,130,000 |
| Modeling Social Behavior (R01) Apply for RFA GM 13 006 Funding Number: RFA GM 13 006 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Grand Challenges in Global Mental Health Integrating Mental Health into Chronic Disease Care Provision in Low and Middle Income Countries (R01) Apply for RFA MH 13 040 Funding Number: RFA MH 13 040 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Increasing Human Resources for Health and Epidemiological Capacity in the Republic of Guyana through a University Training Program under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 1208 Funding Number: CDC RFA GH12 1208 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $440,000 |
| Sober Truth on Preventing Underage Drinking Act Grants Apply for SP 12 003 Funding Number: SP 12 003 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $50,000 |
| Improving Quality of Care and Health Impact through Sustainable, Integrated, Innovative Information System Technologies in Malawi under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 1250 Funding Number: CDC RFA GH12 1250 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $8,000,000 |
| Ancillary Studies in PREDICT HD (U01) Apply for PAR 12 097 Funding Number: PAR 12 097 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA NS 13 001", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.